These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16877492)

  • 21. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
    Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
    Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from type 1 diabetes mellitus with nephropathy.
    Tessari P; Puricelli L; Iori E; Arrigoni G; Vedovato M; James P; Coracina A; Millioni R
    J Proteome Res; 2007 Mar; 6(3):976-86. PubMed ID: 17330940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.
    Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
    Diabetologia; 2004 Oct; 47(10):1789-94. PubMed ID: 15502921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J; Jia R; Bao Y
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy.
    Möllsten A; Marklund SL; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Diabetes; 2007 Jan; 56(1):265-9. PubMed ID: 17192491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice.
    Qing-Hua G; Ju-Ming L; Chang-Yu P; Zhao-Hui L; Xiao-Man Z; Yi-Ming M
    J Diabetes Complications; 2008; 22(6):408-12. PubMed ID: 18413157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes.
    Alvarez-Muñoz P; Mauer M; Kim Y; Rich SS; Miller ME; Russell GB; Lopez-Novoa JM; Caramori ML
    J Diabetes Complications; 2010; 24(4):242-9. PubMed ID: 19395281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells.
    Schmidt AJ; Hemmeter UM; Krieg JC; Vedder H; Heiser P
    J Psychiatr Res; 2009 May; 43(8):818-23. PubMed ID: 19101687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applications of the quick-freezing and deep-etching method to human diabetic nephropathy.
    Moriya T; Ohno S; Tanaka K; Fujita Y
    J Electron Microsc (Tokyo); 2006 Apr; 55(2):69-73. PubMed ID: 16740604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
    Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy.
    Moczulski DK; Fojcik H; Wielgorecki A; Trautsolt W; Gawlik B; Kosiorz-Gorczynska S; Oczko-Wojciechowska M; Wiench M; Strojek K; Zukowska-Szczechowska E; Grzeszczak W
    Diabet Med; 2007 Mar; 24(3):266-71. PubMed ID: 17263765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbation of erythrocyte antioxidant barrier, lipid peroxidation and protein carbonylation in non-diabetic first degree relatives of patients with type 2 diabetes.
    Sathiyapriya V; Selvaraj N; Bobby Z; Agrawal A
    Diabetes Res Clin Pract; 2007 Nov; 78(2):171-5. PubMed ID: 17416436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
    Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.
    El Shazly AH; Mahmoud AM; Darwish NS
    Acta Pharm; 2009 Mar; 59(1):67-73. PubMed ID: 19304559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy].
    Xu JY; Tao LJ; Wang L; Ning WB; Liu JS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):836-40. PubMed ID: 18812664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diminished synthesis of catalase due to the decrease in catalase mRNA in Japanese-type acatalasemia.
    Wen JK; Osumi T; Hashimoto T; Ogata M
    Physiol Chem Phys Med NMR; 1988; 20(3):171-6. PubMed ID: 3244798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits.
    Winiarska K; Szymanski K; Gorniak P; Dudziak M; Bryla J
    Biochimie; 2009 Feb; 91(2):261-70. PubMed ID: 18957317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.